SCANCELL HOLDINGS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.6 GBX | 0.00% |
|
0.00% | -8.57% |
| Mar. 26 | Scancell doses first patient in melanoma-focused trials | AN |
| Mar. 22 | Seneca Growth Capital announces tepid 2023 results | AN |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 10.10 | 11.25 | 16.75 |
| Spread/Res. | -4.95% | -14.67% | -42.69% |
| Spread/Supp. | +0.52% | +0.52% | +3.78% |
| Support | 9.550 | 9.550 | 9.250 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- SCLP Stock
- Charts Scancell Holdings plc
